Hügel S, Horn M, Remkes H, Dienesch C, Neubauer S
Department of Cardiology, Medizinische Universitätsklinik, Würzburg, Germany.
J Cardiovasc Magn Reson. 2001;3(3):215-25. doi: 10.1081/jcmr-100107470.
Angiotensin-converting enzyme (ACE) inhibitors show beneficial long-term hemodynamic effects in chronically infarcted hearts. The purpose of this study was to test whether prevention of the deterioration of mechanical function by ACE inhibitors is related to beneficial effects on high-energy phosphate metabolism that is deranged in heart failure.
Twelve-week old rats were randomly assigned to ligation of the left coronary artery [mycardial infarction (MI)] or sham operation (Sham) and to the ACE inhibitor quinapril (+Q) (6 mg/kg/day per gavage) or placebo treatment. Eight weeks later, cardiac function was measured in the isolated heart by a left ventricular balloon (pressure-volume curves), and energy metabolism of residual intact myocardium was analyzed in terms of total and isoenzyme creatine kinase activity (spectrophotometry), steady-state levels [adenosine triptosphate (ATP), phosphocreatine], and turnover rates (creatine kinase reaction velocity) of high-energy phosphates [31P nuclear magnetic resonance (NMR)] and total creatine content [high-performance liquid chromatography (HPLC)].
Quinapril prevented post-MI hypertrophy and partially prevented left ventricular contractile dysfunction [maximum left ventricular developed pressure 166+/-6, 83+/-16 (p < 0.05 MI vs. Sham), 139+/-13 mm Hg (p < 0.05 quinapril treated vs. untreated) in Sham, MI and MI+Q hearts]. Residual intact failing myocardium showed a 17% decrease of MM-CK and a 16% decrease of mito-CK activity. Total creatine was reduced by 23%, phosphocreatine by 26% and CK reaction velocity by 30%. Parallel to improved function, treatment with quinapril largely prevented the impairment of energy metabolism occuring post-MI.
quinapril treatment results in an improvement of high-energy phosphate metabolism, of energy reserve via the creatine kinase reaction, and of contractile performance post-MI.
血管紧张素转换酶(ACE)抑制剂对慢性梗死心脏具有有益的长期血流动力学效应。本研究旨在测试ACE抑制剂预防机械功能恶化是否与对心力衰竭时紊乱的高能磷酸代谢的有益作用有关。
将12周龄大鼠随机分为左冠状动脉结扎组[心肌梗死(MI)]或假手术组(Sham),并分别给予ACE抑制剂喹那普利(+Q)(6mg/kg/天,灌胃)或安慰剂治疗。8周后,通过左心室球囊(压力-容积曲线)测量离体心脏的心脏功能,并根据总肌酸激酶活性和同工酶肌酸激酶活性(分光光度法)、稳态水平[三磷酸腺苷(ATP)、磷酸肌酸]以及高能磷酸盐的周转率(肌酸激酶反应速度)[31P核磁共振(NMR)]和总肌酸含量[高效液相色谱(HPLC)]分析残余完整心肌的能量代谢。
喹那普利可预防心肌梗死后的心肌肥大,并部分预防左心室收缩功能障碍[假手术组、心肌梗死组和心肌梗死+喹那普利治疗组心脏的最大左心室舒张末压分别为166±6、83±16(心肌梗死组与假手术组相比,p<0.05)、139±13mmHg(喹那普利治疗组与未治疗组相比,p<0.05)]。残余完整的衰竭心肌显示MM-CK降低17%,线粒体CK活性降低16%。总肌酸降低23%,磷酸肌酸降低26%,CK反应速度降低30%。与功能改善并行,喹那普利治疗在很大程度上预防了心肌梗死后发生的能量代谢损害。
喹那普利治疗可改善心肌梗死后的高能磷酸代谢、通过肌酸激酶反应的能量储备以及收缩功能。